retatrutide peptide vs tirzepatide Tirzepatide: July 2026 Comparison Retatrutide vs Tirzepatide: Key Differences

Abruptly stopping a GLP-1 can mean rebound appetite, weight regain, and worsening blood sugar control

Trials funded by Novo Nordisk have shown a mean weight loss of up to 15% from oral semaglutide in adults without diabetes

How Does Retatrutide Dosing Differ From Semaglutide Dosing

Harvard Pilgrim Medicare Advantage plans can cover Wegovy for the cardiovascular risk-reduction indication (FDA-approved for adults with established CVD who are overweight or obese) with prior authorization

Mounjaro is a GLP-1 receptor agonist and mimics glucose-dependent insulinotropic polypeptide (GIP), which is a hormone that helps release food after eating